Anas Gazzah

Anas Gazzah

UNVERIFIED PROFILE

Are you Anas Gazzah?   Register this Author

Register author
Anas Gazzah

Anas Gazzah

Publications by authors named "Anas Gazzah"

Are you Anas Gazzah?   Register this Author

42Publications

1783Reads

47Profile Views

A phase 1b study of afatinib in combination with standard-dose cetuximab in patients with advanced solid tumours.

Eur J Cancer 2018 11 1;104:1-8. Epub 2018 Oct 1.

Medical Oncology Division, START Madrid Centro Integral Oncológico Clara Campal, Calle de Oña, 10, 28050, Madrid, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2018.07.011DOI Listing
November 2018

Are phase I trials safe for older patients?

J Geriatr Oncol 2018 03 8;9(2):87-92. Epub 2017 Sep 8.

Drug Development Department (DITEP), Gustave Roussy Cancer Campus, Villejuif Cedex F-94805, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jgo.2017.08.012DOI Listing
March 2018

Human epidermal receptor family inhibitors in patients with ERBB3 mutated cancers: Entering the back door.

Eur J Cancer 2018 03 3;92:1-10. Epub 2018 Feb 3.

Drug Development Department, Gustave Roussy, Department of Medical Oncology, Faculté de Medicine Paris-Sud XI, Kremlin-Bicêtre, France; Gustave Roussy Department of Medical Oncology, Faculté de Medicine Paris-Sud XI, Kremlin-Bicêtre, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2017.12.020DOI Listing
March 2018

Late-occurring nivolumab-induced cryptogenic organising pneumonia mimicking lung progression in a patient with metastatic non-small cell lung cancer.

Eur J Cancer 2017 11 13;85:155-157. Epub 2017 Sep 13.

Drug Development Department (DITEP), Gustave Roussy, and University Paris-Sud, Villejuif, France; INSERM U981, Gustave Roussy, University Paris XI, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2017.07.049DOI Listing
November 2017

Prognostic value of HLA-A2 status in advanced non-small cell lung cancer patients.

Lung Cancer 2017 10 29;112:10-15. Epub 2017 Jul 29.

Medical Oncology Department, Gustave Roussy, Villejuif, France; University Paris-Saclay, Faculté de Médecine, Le Kremlin Bicêtre, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2017.07.004DOI Listing
October 2017

Phase I dose-escalation study of milciclib in combination with gemcitabine in patients with refractory solid tumors.

Cancer Chemother Pharmacol 2017 Jun 19;79(6):1257-1265. Epub 2017 Apr 19.

Drug Development Department (DITEP), Gustave Roussy Cancer Centre, Université Paris-Saclay, 114 Rue Eduard Vaillant, 94805, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-017-3303-zDOI Listing
June 2017

Predictive factors of renal toxicities related to anti-VEGFR multikinase inhibitors in phase 1 trials.

Invest New Drugs 2017 02 25;35(1):79-86. Epub 2016 Oct 25.

Clinical Pharmacology, Henri Mondor Teaching Hospital, 51 avenue du Maréchal de Lattre de Tassigny, Assistance Publique - Hôpitaux de Paris, 94000, Créteil, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-016-0402-3DOI Listing
February 2017

A never-smoker lung adenocarcinoma patient with a MET exon 14 mutation (D1028N) and a rapid partial response after crizotinib.

Invest New Drugs 2016 06 18;34(3):397-8. Epub 2016 Feb 18.

Drug development Department (DITEP), Gustave Roussy, 114 rue Edouard Vaillant, 94805, Villejuif, France.

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007%2Fs10637-016-03
Web Search
http://link.springer.com/10.1007/s10637-016-0332-0
Publisher Site
http://dx.doi.org/10.1007/s10637-016-0332-0DOI Listing
June 2016

Phase I Dose-Escalation Study of JNJ-42756493, an Oral Pan-Fibroblast Growth Factor Receptor Inhibitor, in Patients With Advanced Solid Tumors.

J Clin Oncol 2015 Oct 31;33(30):3401-8. Epub 2015 Aug 31.

Josep Tabernero, Rodrigo Dienstmann, Barbara Adamo, and Jordi Rodon, Vall d'Hebron University Hospital and Institute of Oncology, Universitat Autònoma de Barcelona, Barcelona; Emiliano Calvo, START Madrid, Centro Integral Oncológico Clara Campal; Victor Moreno, START Madrid, Hospital Fundación Jiménez Díaz, Madrid, Spain; Rastislav Bahleda, Anas Gazzah, and Jean-Charles Soria, Gustave Roussy Cancer Campus and University Paris-Sud, Villejuif; Antoine Italiano, Institut Bergonié, Bordeaux, France; Jeffrey R. Infante, Sarah Cannon Research Institute, Nashville, TN; Alain Mita, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA; Bob Zhong, Suso J. Platero, Moitreyee Chatterjee-Kishore, Vijay Peddareddigari, and Feng R. Luo, Janssen Research and Development, Raritan, NJ; and Johan W. Smit and Kim Stuyckens, Janssen Research and Development, Beerse, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.60.7341DOI Listing
October 2015

Crizotinib Improves Osteoarthritis Symptoms in a ROS1-Fusion Advanced Non-Small Cell Lung Cancer Patient.

J Thorac Oncol 2015 Aug;10(8):e72-3

*Thoracic Oncology Section, Gustave Roussy Cancer Campus, Villejuif, France; and †Thoracic Oncology Section, University of Paris-Sud, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000561DOI Listing
August 2015

Molecular guided therapy for advanced pancreatic cancer patients with PI3K activated mutation: vision or illusion?

Onco Targets Ther 2013 20;6:95-7. Epub 2013 Feb 20.

SITEP (Service des Innovations Therapeutiques Précoces), Department of Medicine, Institut Gustave Roussy, Paris XI University, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/OTT.S38520DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3581357PMC
March 2013

[Focus on targeting the Ras-MAPK pathway: the Mek inhibitors].

Bull Cancer 2012 Sep;99(9):865-74

Institut Gustave-Roussy, 114, rue Édouard-Vaillant, 94805 Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1684/bdc.2012.1632DOI Listing
September 2012

[Breast cancer in the elderly].

Bull Cancer 2008 May;95 FMC Onco:F51-6

Département d'oncologie médicale, Centre René-Huguenin, 35, rue Dailly, 92210 Saint-Cloud et Programme d'action concertée Gerico de la Fédération nationale des centres de lutte contre le cancer, 101, rue de Tolbiac, 75654 Paris Cedex 13, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1684/bdc.2007.0562DOI Listing
May 2008